<?xml version="1.0" encoding="UTF-8"?>
<p>Early attempts to develop safe and effective vaccines for SARS or MERS have been unsuccessful. It is hypothesised that current efforts will take time to develop, and may or may not be efficacious for this or future coronavirus pandemics [
 <xref rid="C10" ref-type="bibr">10</xref>, 
 <xref rid="C26" ref-type="bibr">26</xref>â€“
 <xref rid="C28" ref-type="bibr">28</xref>]. Many potential therapies have been proposed with a subset currently undergoing investigation [
 <xref rid="C29" ref-type="bibr">29</xref>, 
 <xref rid="C30" ref-type="bibr">30</xref>]. Meanwhile, extensive efforts to date have been appropriately focused on screening, identification, and containment through the collaboration and coordination between global and local health and governmental agencies [
 <xref rid="C31" ref-type="bibr">31</xref>]. Unfortunately, these public health efforts have had, at best, mixed success curbing the spread of the pandemic [
 <xref rid="C32" ref-type="bibr">32</xref>]. Given the rapid spread of SARS-COV2 and the significant morbidity and mortality associated with infection, it behooves the medical community to evaluate and leverage novel treatments for efficacy, especially if they are already available and have an established safety profile.
</p>
